Source comparison
TB-500 Research Exercise Considerations Comparison
TB-500 Administration Timing Post-injury or damage induction 24–48h pre-exercise OR 6–12h post-exercise Timing determines whether TB-500 acts during acute inflammatory phase or proliferative repair phase. Fundamentally different cellular processes Dosing Frequ
This comparison does not assign a generated winner or score.
- TB-500 Administration Timing
- Post-injury or damage induction
- 24–48h pre-exercise OR 6–12h post-exercise
- Timing determines whether TB-500 acts during acute inflammatory phase or proliferative repair phase. Fundamentally different cellular processes
- Dosing Frequency
- Single dose or weekly dosing without mechanical load
- Dosing aligned with training schedule (e.g., every 7 days with 3x/week training)
- Exercise increases metabolic clearance and tissue demand. Protocols without alignment risk subtherapeutic tissue levels
- Primary Outcome Markers
- CK, LDH, IL-6 (general inflammation)
- G-actin/F-actin ratio, FAK phosphorylation, MMP-2/9 activity (mechanism-specific)
- Generic markers can't isolate TB-500 effects from natural training adaptation response
- Endogenous Tβ4 Measurement
- Often omitted (assumed negligible)
- REQUIRED. Exercise upregulates endogenous Tβ4 3–5x baseline
- Without baseline measurement, impossible to separate exogenous TB-500 from natural exercise-induced Tβ4 increase
- Mechanical Load Quantification
- Not applicable (static models)
- Load volume, intensity, and frequency must be standardised
- TB-500 effects scale with mechanical stress level. Uncontrolled load variability confounds all downstream measurements
- Professional Assessment
- Adequate for basic tissue repair research questions
- Required design modifications for valid exercise physiology research. Standard protocols produce confounded data